Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-1beta | 3 | 2013 | 75 | 0.420 |
Why?
|
| Dipeptidases | 1 | 2013 | 9 | 0.410 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 16 | 0.410 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 173 | 0.340 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 239 | 0.340 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 247 | 0.330 |
Why?
|
| Trans-Activators | 3 | 2013 | 192 | 0.320 |
Why?
|
| Liver | 1 | 2013 | 511 | 0.320 |
Why?
|
| MicroRNAs | 2 | 2013 | 518 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 257 | 0.260 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 18 | 0.260 |
Why?
|
| STAT1 Transcription Factor | 1 | 2007 | 34 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 384 | 0.150 |
Why?
|
| Cell Line | 4 | 2012 | 1410 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 16 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 27 | 0.100 |
Why?
|
| Genes, Immediate-Early | 1 | 2013 | 10 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 67 | 0.100 |
Why?
|
| Aryldialkylphosphatase | 1 | 2012 | 14 | 0.090 |
Why?
|
| Osteomyelitis | 1 | 2012 | 20 | 0.090 |
Why?
|
| Collagen | 1 | 2013 | 181 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 2676 | 0.090 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 49 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 58 | 0.090 |
Why?
|
| Disease Progression | 1 | 2013 | 667 | 0.080 |
Why?
|
| Mice | 3 | 2013 | 6644 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 218 | 0.080 |
Why?
|
| ADAM Proteins | 1 | 2009 | 20 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 734 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 592 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 81 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 154 | 0.070 |
Why?
|
| Humans | 9 | 2013 | 43102 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 45 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 49 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 55 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2013 | 735 | 0.060 |
Why?
|
| Tyrosine | 1 | 2007 | 120 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 65 | 0.060 |
Why?
|
| Animals | 4 | 2013 | 16992 | 0.060 |
Why?
|
| Young Adult | 2 | 2013 | 5080 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2007 | 986 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2003 | 10 | 0.050 |
Why?
|
| Adult | 3 | 2013 | 13872 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 8 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 423 | 0.040 |
Why?
|
| Prognosis | 2 | 2013 | 861 | 0.040 |
Why?
|
| Male | 3 | 2013 | 23409 | 0.040 |
Why?
|
| Female | 3 | 2013 | 24698 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 1271 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 532 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 31 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2013 | 30 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 15 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 68 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2013 | 104 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 204 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 244 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 277 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 18 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 37 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 30 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 114 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 67 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1285 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 100 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2009 | 125 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 374 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1177 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 8214 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 458 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 652 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 883 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 436 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 968 | 0.020 |
Why?
|
| Hela Cells | 1 | 2008 | 376 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1003 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 12222 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1621 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 526 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 372 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 5 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2003 | 22 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 73 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 100 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 2853 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 314 | 0.010 |
Why?
|
| Mammals | 1 | 2003 | 112 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 416 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 518 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 213 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 3994 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6081 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 876 | 0.010 |
Why?
|